{"organizations": [], "uuid": "d3a42cd45c2458ec86218684d7cb9851c5d523a8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-edwards-lifesciences-says-fda-gran/brief-edwards-lifesciences-says-fda-grants-de-novo-request-for-acumen-hypotension-prediction-index-software-idUSFWN1R10PA", "country": "US", "domain_rank": 408, "title": "BRIEF-Edwards Lifesciences Says FDA Grants De Novo Request For Acumen Hypotension Prediction Index Software​", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-19T14:41:00.000+02:00", "replies_count": 0, "uuid": "d3a42cd45c2458ec86218684d7cb9851c5d523a8"}, "author": "", "url": "https://www.reuters.com/article/brief-edwards-lifesciences-says-fda-gran/brief-edwards-lifesciences-says-fda-grants-de-novo-request-for-acumen-hypotension-prediction-index-software-idUSFWN1R10PA", "ord_in_thread": 0, "title": "BRIEF-Edwards Lifesciences Says FDA Grants De Novo Request For Acumen Hypotension Prediction Index Software​", "locations": [], "entities": {"persons": [{"name": "edwards", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda grants de novo", "sentiment": "negative"}, {"name": "index software​ reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "edwards lifesciences corp", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "lifesciences corp", "sentiment": "none"}, {"name": "novo", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 43 PM / in 11 minutes BRIEF-Edwards Lifesciences Says FDA Grants De Novo Request For Acumen Hypotension Prediction Index Software​ Reuters Staff 1 Min Read March 19 (Reuters) - Edwards Lifesciences Corp: * EDWARDS LIFESCIENCES CORP - ‍U.S. FDA GRANTED DE NOVO REQUEST FOR EDWARDS’ ACUMEN HYPOTENSION PREDICTION INDEX SOFTWARE​ Source text for Eikon:  ", "external_links": [], "published": "2018-03-19T14:41:00.000+02:00", "crawled": "2018-03-19T15:00:02.046+02:00", "highlightTitle": ""}